Navigation Links
FDA approves CLARINEX-D 12 HOUR for seasonal allergic rhinitis

Food and Drug Association as approved the drug CLARINEX-D 12 HOUR for use in treating symptoms of seasonal allergic rhinitis. // CLARINEX-D 12 HOUR is a drug containing a combination of desloratadine 2.5 mg and pseudoephedrine sulfate, USP 120 mg. FDA has approved the drug for use in persons above 12 years of age. The drug has been found effective in curing persons with nasal and non-nasal symptoms occurring due to seasonal allergic rhinitis. Two clinical studies in 1,248 patients have found that the drug CLARINEX-D is found to be more effective in controlling allergic symptoms than the drug psueoephedrine alone.

The drug contains a delivery system, which delivers psudoephedrine in a consistent manner, and a dosage of two times a day of the nasal drug is found to be effective in controlling symptoms of allergic rhinitis and relieves nasal blockage and congestion, running nose, sneezing, watery eyes and itchy throat. The drug is found to be very effective in controlling allergic symptoms but has been found to be associated with mild side effects of insomnia, headache, pharyngitis, weakness and fatigue.


'"/>




Page: 1

Related medicine news :

1. FDA approves new device to treat womens bleeding disorder
2. FDA approves surgical gel
3. FDA approves drug for rare liver disease
4. FDA approves first pocket-sized EKG machine
5. FDA approves Watson Pharmaceuticals Oxytrol patch
6. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
7. Madras High Court Disapproves of Comparative Advertisements
8. FDA approves Phase 0 trial which tests experimental drugs on humans
9. Study disapproves a new Asthma inhaler
10. GMC Disapproves Internet Doctor
11. Old flu drugs not effective against seasonal influenza
Post Your Comments:
(Date:12/3/2008)...r 3, 2008 (BRONX, NY) A new study led by researc...hiva University has clarified how two major varian...gic complications. The finding, published in Jou... drugs that could prevent HIV-associated dementia,... in people with AIDS. Even with anti-retroviral dr...
(Date:12/3/2008)...o had aggressive surgeries were free of tumor recu... , ROCHESTER, Minn., Dec. 3 /PRNewswire-USNew...nts with low-grade gliomas survived longest when t... remove the entire tumor. If safely removing the e...gnificantly longer when surgery was followed by ra...
(Date:12/3/2008)....J., Dec. 3 Memory Pharm...d that, on December 3, 2008, the Company,received...ns Panel (the,"Panel") that the Panel has determi...ASDAQ Capital Market. However, the Company was al...ring Review Council (the "Review Council") has,ca...
(Date:12/3/2008)... Three and Half Times Greater Than Entire U.S. Eco...ire/ -- If the federal government stopped the Medi...ecting no more payroll taxes and allowing no more ...2 trillion to those who have already earned these ... Center for Policy Analysis (NCPA). , , "...
Breaking Medicine News(10 mins):Health News:Study sheds light on causes of HIV dementia 2Health News:Study sheds light on causes of HIV dementia 3Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 2Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 3Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2
...roid (budesonide) coupled with a long-acting beta2...cant improvement of // asthma symptoms with less r...archers according to a new study. For the study th...icine on asthma symptoms in 2,760 asthma patients ...
...a recent study researchers say weight gain after a...cer risk for postmenopausal women who // are not t...rchers sampled nearly 62,000 women, ages 50 to 74,...e 18 and their current weight. Since then, the wom...
... thought to be an autoimmune disorder, where white... fibers of the central nervous system. Statistics ... . // A new study shows weightlifting can help pat...causes muscle weakness and fatigue, which leads to...
...e folate are less likely to develop high blood pre...t study .// For the study researchers analyzed da...n 156,000 women. Researchers gave the women quest...e and supplemental folic acid intake. None of the ...
Other Medicine News:
(Date:12/2/2008)...tCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biop...y antibodies for the treatment of cancer, inflamma... it has entered into an agreement expanding its Co...sbridge Capital Limited, a private investment grou...has committed to provide up to $75 million of capi...
(Date:12/1/2008)...stCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: V...the world,s leading medical journals, results of c...xperimental compound tasimelteon (VEC-162). The p...atonin agonist tasimelteon (VEC-162) for transient...ontrolled multicentre trials." Results are reporte...
(Date:12/1/2008)...oche announced today that a,comparative study con...nd,discomfort associated with blood glucose testi...ems and lancing devices were deemed least painful....U-CHEK Aviva and ACCU-CHEK Compact,Plus blood glu...x, ACCU-CHEK,Softclix and ACCU-CHEK Softclix Plus...
(Date:12/1/2008)...icy , , ROCHESTER, Minn., Dec. 1 /PRNewswi...ds the use of the drug therapy etanercept ineffect...ammation of the liver caused by excessive consumpt...shed in the December issue of Gastroenterology (...O ALERT: Additional audio and video resources, inc...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Aerolase Retains SMH Capital Inc to Advise on Corporate Expansion 7800 1Aerolase Retains SMH Capital Inc to Advise on Corporate Expansion 7800 2tootoo com 3A Chinas Farmers Welcome the New Trend of Organic Farming 7797 1tootoo com 3A Chinas Farmers Welcome the New Trend of Organic Farming 7797 2NOVAVAX CEO to Present at 2008 UBS Global Life Sciences Conference 3101 1High blood pressure takes big toll on small filtering units of the kidney 4967 1High blood pressure takes big toll on small filtering units of the kidney 4967 2
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm). Angled 45 degrees, 4mm from end.
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)
... most versatile diagnostic tool in the eye care in...aucoma, diabetic retinopathy, age-related macular ...TA is the only system in the market that covers th...nerve areas in one session, the only system which ...
For diagnostic and operative treatment of hand and wrist bones. The use of this distraction device allows fracture reduction or widening of the space between bones.
Medicine Products: